Evaluation of BRCAPRO risk assessment model in patients with ductal carcinoma in situ who underwent clinical BRCA genetic testing.

Evaluation of BRCAPRO risk assessment model in patients with ductal carcinoma in situ who underwent clinical BRCA genetic testing.

The authors retrospectively aimed to determine which of the following 3 scenarios, related to DCIS entry into BRCAPRO, predicted BRCA mutation status more accurately: 1) DCIS as an invasive breast cancer (IBC) entered using the actual age of diagnosis, 2) DCIS as IBC entered with 10 years added to t...

Full description

Bibliographic Details
Main Authors: Nisreen eElsayegh, Angelica M. Gutierrez Barrera, Kimberly I. Muse, Heather eLin, Henry M Kuerer, Monica eHelm, Jennifer K. Litton, Banu K. Arun
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-04-01
Series:Frontiers in Genetics
Subjects:
Genes
Genetics
gene
BRCA1
Ductal carcinoma in situ (DCIS)
BRCAPRO
Online Access:http://journal.frontiersin.org/Journal/10.3389/fgene.2016.00071/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fgene.2016.00071/full

Similar Items